Vol 15, No 3 (2008)
Original articles
Published online: 2008-04-14
Outcome of patients with stable angina pectoris treated with or without percutaneous coronary intervention
Cardiol J 2008;15(3):226-229.
Abstract
Background: To assess the outcome of patients with stable angina pectoris treated with
percutaneous coronary intervention versus medically treated patients.
Methods: Eighty patients with stable angina pectoris and coronary stenosis as confirmed in coronary angiography were treated with (n = 31) or without (n = 49) percutaneous coronary intervention in our department. All patients received optimal medical therapy and were followed up for a period of 24 months.
Results: Baseline clinical characteristics, including risk factors of coronary heart disease and coronary lesion type did not differ between the two groups (all p > 0.05). There was no significant difference in major adverse cardiac events (22.4% vs. 22.6%) during the 24 month follow-up between the two groups (p > 0.05).
Conclusions: Percutaneous coronary intervention did not provide extra benefit in this group of patients with stable angina pectoris receiving standard medical treatment in terms of 24 months major adverse outcomes. (Cardiol J 2008; 15: 226-229)
Methods: Eighty patients with stable angina pectoris and coronary stenosis as confirmed in coronary angiography were treated with (n = 31) or without (n = 49) percutaneous coronary intervention in our department. All patients received optimal medical therapy and were followed up for a period of 24 months.
Results: Baseline clinical characteristics, including risk factors of coronary heart disease and coronary lesion type did not differ between the two groups (all p > 0.05). There was no significant difference in major adverse cardiac events (22.4% vs. 22.6%) during the 24 month follow-up between the two groups (p > 0.05).
Conclusions: Percutaneous coronary intervention did not provide extra benefit in this group of patients with stable angina pectoris receiving standard medical treatment in terms of 24 months major adverse outcomes. (Cardiol J 2008; 15: 226-229)
Keywords: stable angina pectorispercutaneous coronary interventionmedicationoutcome